Scilex Holding Co (SCLX) Form 10-Q — May 20, 2026
Scilex Holding Company reported a net loss of $45.7 million for the three months ended March 31, 2026, driven by operating losses and significant unrealized losses on equity investments and digital assets. The company generated $8.6 million in revenue, primarily from its commercial products ZTlido, ELYXYB, and GLOPERBA. The filing raises substantial doubt about the company's ability to continue as a going concern, citing negative working capital of $459.8 million and only $3.4 million in cash. Management states that future operations depend on successful equity offerings, debt financings, or strategic transactions, none of which are guaranteed.
Key figures
- Revenue
- 8613000
- Total Assets
- 293635000
- Cash Position
- 3351000
- Shares Outstanding
- 8491267
- Digital Assets Value
- 65345000
- Litigation Damages Sought
- 100000000
- Equity Method Investment Value
- 79098000
Price after filing
Close on the filing date to close N calendar days later (from $6.01). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.